New hope for sickest babies: common supplement could fight deadly infection
NCT ID NCT07380347
Summary
This study aims to see if adding the antioxidant N-acetylcysteine (NAC) to standard antibiotic treatment helps newborns with sepsis get better faster. It will involve 50 newborns with a serious infection and measure if NAC reduces organ damage, shortens hospital stays, and lowers the risk of death. The goal is to control this life-threatening condition by targeting harmful inflammation and cell damage caused by the infection.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEONATAL SEPSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.